FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317435814> ?p ?o ?g. }

• W4317435814 endingPage "600" @default.
• W4317435814 startingPage "600" @default.
• W4317435814 abstract "Resectable hepatocellular carcinoma (HCC) has poor prognosis because of its high recurrence rate. Immunotherapy has been tried for neoadjuvant therapy as it has shown excellent performance in the treatment of advanced HCC. This systematic review and meta-analysis aimed to assess the reported efficacy and safety of neoadjuvant immune checkpoint inhibitors (ICIs) for resectable HCC. Electronic databases, including PubMed (MEDLINE), Embase, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify published and ongoing studies evaluating the efficacy and safety of neoadjuvant ICIs for resectable HCC up to October 2022. The odds ratio (OR) and 95% confidence interval (CI) were calculated. Heterogeneity and subgroup analyses were performed, and data quality was assessed. The study was registered with PROSPERO (registration number: CRD42022371495). A total of 193 patients from 9 studies were included in this meta-analysis. The overall pathological complete response (pCR) rate was 12.9% (95%CI, 6.7-19.1%), and major pathological response (MPR) rate was 27.3% (95%CI, 15.1-39.4%), indicating a favorable association with neoadjuvant ICIs (pCR: OR = 0.17, p < 0.00001; MPR: OR = 0.38, p = 0.001). The pooled OR values for the incidence of grade 3 to 4 treatment-related adverse events and surgical delay rate were 0.26 and 0.05, respectively, which were significantly in favor of neoadjuvant ICIs (p < 0.0001; p < 0.00001, respectively). The subgroup analyses did not demonstrate superiority of one ICI over another ICI or combination therapy. The present study found that neoadjuvant ICIs were well tolerated by patients with resectable HCC and conferred therapeutic benefits in view of histopathological response results." @default.
• W4317435814 created "2023-01-19" @default.
• W4317435814 creator A5022615036 @default.
• W4317435814 creator A5045046078 @default.
• W4317435814 creator A5050239493 @default.
• W4317435814 creator A5073070877 @default.
• W4317435814 creator A5086752003 @default.
• W4317435814 date "2023-01-18" @default.
• W4317435814 modified "2023-10-16" @default.
• W4317435814 title "Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis" @default.
• W4317435814 cites W2074898491 @default.
• W4317435814 cites W2081871084 @default.
• W4317435814 cites W2101031676 @default.
• W4317435814 cites W2156906256 @default.
• W4317435814 cites W2333367339 @default.
• W4317435814 cites W2521503673 @default.
• W4317435814 cites W2606367731 @default.
• W4317435814 cites W2783634552 @default.
• W4317435814 cites W2791328450 @default.
• W4317435814 cites W2888941300 @default.
• W4317435814 cites W2894584497 @default.
• W4317435814 cites W2894796660 @default.
• W4317435814 cites W2904099327 @default.
• W4317435814 cites W2953067331 @default.
• W4317435814 cites W2965242861 @default.
• W4317435814 cites W2987436342 @default.
• W4317435814 cites W2990602950 @default.
• W4317435814 cites W2998795792 @default.
• W4317435814 cites W3000282923 @default.
• W4317435814 cites W3000311037 @default.
• W4317435814 cites W3003310139 @default.
• W4317435814 cites W3006930853 @default.
• W4317435814 cites W3015035400 @default.
• W4317435814 cites W3025022288 @default.
• W4317435814 cites W3027588727 @default.
• W4317435814 cites W3033038192 @default.
• W4317435814 cites W3040152669 @default.
• W4317435814 cites W3041284694 @default.
• W4317435814 cites W3042708039 @default.
• W4317435814 cites W3045387409 @default.
• W4317435814 cites W3090413519 @default.
• W4317435814 cites W3112450557 @default.
• W4317435814 cites W3114582868 @default.
• W4317435814 cites W3118401794 @default.
• W4317435814 cites W3118615836 @default.
• W4317435814 cites W3128131226 @default.
• W4317435814 cites W3128646645 @default.
• W4317435814 cites W3132841322 @default.
• W4317435814 cites W3163488209 @default.
• W4317435814 cites W3181229664 @default.
• W4317435814 cites W3186127018 @default.
• W4317435814 cites W3187065261 @default.
• W4317435814 cites W3196115239 @default.
• W4317435814 cites W3197334239 @default.
• W4317435814 cites W3212466965 @default.
• W4317435814 cites W4205460569 @default.
• W4317435814 cites W4206656883 @default.
• W4317435814 cites W4207067502 @default.
• W4317435814 cites W4211183069 @default.
• W4317435814 cites W4214681573 @default.
• W4317435814 cites W4224325284 @default.
• W4317435814 cites W4226382697 @default.
• W4317435814 cites W4283770123 @default.
• W4317435814 cites W4283812631 @default.
• W4317435814 cites W4285740307 @default.
• W4317435814 cites W4286295501 @default.
• W4317435814 cites W4294838953 @default.
• W4317435814 cites W4295816808 @default.
• W4317435814 cites W4295819831 @default.
• W4317435814 cites W4296742945 @default.
• W4317435814 doi "https://doi.org/10.3390/cancers15030600" @default.
• W4317435814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36765557" @default.
• W4317435814 hasPublicationYear "2023" @default.
• W4317435814 type Work @default.
• W4317435814 citedByCount "2" @default.
• W4317435814 countsByYear W43174358142023 @default.
• W4317435814 crossrefType "journal-article" @default.
• W4317435814 hasAuthorship W4317435814A5022615036 @default.
• W4317435814 hasAuthorship W4317435814A5045046078 @default.
• W4317435814 hasAuthorship W4317435814A5050239493 @default.
• W4317435814 hasAuthorship W4317435814A5073070877 @default.
• W4317435814 hasAuthorship W4317435814A5086752003 @default.
• W4317435814 hasBestOaLocation W43174358141 @default.
• W4317435814 hasConcept C121608353 @default.
• W4317435814 hasConcept C126322002 @default.
• W4317435814 hasConcept C143998085 @default.
• W4317435814 hasConcept C156957248 @default.
• W4317435814 hasConcept C17744445 @default.
• W4317435814 hasConcept C187960798 @default.
• W4317435814 hasConcept C197934379 @default.
• W4317435814 hasConcept C199539241 @default.
• W4317435814 hasConcept C2776478404 @default.
• W4317435814 hasConcept C2778019345 @default.
• W4317435814 hasConcept C2778292576 @default.
• W4317435814 hasConcept C2779473830 @default.
• W4317435814 hasConcept C44249647 @default.
• W4317435814 hasConcept C530470458 @default.
• W4317435814 hasConcept C71924100 @default.

• next